RhumbLine Advisers’s Upstream Bio UPB Stock Holding History
Bought
Maintained
Sold
Other funds holding UPB
RhumbLine Advisers's UPB Position: Q3 2026 in Review
RhumbLine Advisers increased its Upstream Bio (UPB) stake by 0.14% in Q3 2026, buying an estimated $399 and bringing the position to 42,445 shares worth $224K. The position accounts for ﹤0.01% of the portfolio, ranked #3207.
RhumbLine Advisers first reported a position in UPB in Q4 2024 and has held it in 8 quarters since. The position peaked at $1.13M in Q4 2025. 135 funds tracked by Wall St. Rank hold UPB as of Q3 2026.
- RhumbLine Advisers held 42,445 shares of Upstream Bio worth $224K as of Q3 2026.
- RhumbLine Advisers bought 61 Upstream Bio shares in Q3 2026, an estimated $399.
- Upstream Bio made up ﹤0.01% of RhumbLine Advisers's portfolio in Q3 2026, its #3207 holding.
- RhumbLine Advisers first reported a position in Upstream Bio in Q4 2024 and has held it in 8 quarters since.
- RhumbLine Advisers's Upstream Bio position peaked at $1.13M in Q4 2025.
- 135 funds tracked by Wall St. Rank held Upstream Bio as of Q3 2026.
Based on RhumbLine Advisers's 13F filing for Q3 2026, filed 10 Nov 2026.